Medical Device News Magazine

New Scalable Options for Panther System Launches in the US and Europe

Hologic Reports Panther Scalable Solutions Are Commercially Available in These Markets

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The Panther Scalable Solutions (PSS) portfolio are now commercially available in the United States and Europe, reports Hologic today. These new optional configurations, which represent Hologic’s next generation of molecular diagnostics innovation, will allow laboratories to scale their instrumentation to meet testing demands in both their current workflow and their future growth plans.

“Our laboratory partners seek continuing efficiency and consolidation, and we are observing that trend in real-time, with more Panther instruments in the field running multiple assays than ever before”

“Our laboratory partners seek continuing efficiency and consolidation, and we are observing that trend in real-time, with more Panther instruments in the field running multiple assays than ever before,” said Kevin Thornal, president, Diagnostic Solutions Division at Hologic. “In the tenth year since launching the Panther system, we are excited to add expanded capabilities to our market-leading molecular diagnostic platform.”

The Panther system, launched in Europe in 2010, offers random access and full automation for molecular testing. It provides a broad assay menu that includes tests for women’s health, sexually transmitted infections (STIs), respiratory health, and viral load, as well as Open Access functionality for laboratory-developed tests (LDTs). This broad menu enables labs to consolidate molecular testing onto a single platform.

Within Panther Scalable Solutions, the Panther system functions as the foundation for optional add-ons. These add-ons include Panther Fusion, which launched in 2016 and provides additional IVD menu and the Open Access functionality, the now available Panther Plus and Panther Link, as well as the upcoming Panther Trax.

Taken together, these configurable options address the needs of today’s laboratories, allowing them to increase operational capacity and testing volumes at their own pace while building on the flexibility and streamlined user experience they require. Panther Scalable Solutions allows laboratories to choose custom configurations that best suit their needs and testing volumes as they evolve over time. These new options expand upon the proven performance and reliability of the Panther system.

The new optional configurations include:

  • Panther Plus, which adds flexibility, capacity and throughput to the existing Panther system. With Panther Plus, labs can load more consumables directly on the instrument, allowing even greater walkaway time (up to 13.5 consecutive hours). Both fluids and waste can be changed while tests are in process, and an option for automatic liquid waste disposal is available. These features allow an additional 210 tests to be run in 24 hours, providing a total throughput of greater than 1,200 patient samples in that time. Panther Plus is FDA-approved and CE-Marked and is now available in the United States and Europe.
  • Panther Link is a software solution that provides additional efficiencies by creating a virtual connection that allows multiple Panther instruments to communicate with one another and function within a singular, streamlined workflow. Linked instruments can share information such as reagent kits and reflex test orders, enabling more efficient reagent utilization and improved turnaround time. A dashboard command feature allows technicians to monitor instrument inventories, maintenance tasks and test results on a single screen from a centralized location. Panther Link is FDA-approved and CE-Marked and is now available in the United States and Europe.

In addition, Hologic is developing Panther Trax, which will offer the ultimate in lab automation by physically and electronically linking multiple Panther instruments together into a single, powerful workcell that allows labs to increase testing volumes without increasing staff. Panther Trax is expected to be available in the United States and Europe later in 2020.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”